Sign in

CIK 0001636282 · Large accelerated filer

Spyre Therapeutics, Inc.

Sign in to watch
Ticker
SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464312787
Phone
6176515940
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aeglea BioTherapeutics, Inc.
  1. 4 Insider Changes in Ownership
  2. 144 Insider Sale of Securities
  3. 144 Insider Sale of Securities
  4. EFFECT Other Notice of Effectiveness
  5. POS AM Other Post-effective Amendment for Registration Statement
  6. CORRESP Other Correspondence Between Filers and SEC Staff
  7. UPLOAD Other SEC-generated Letter
  8. S-3 Offering Registration Statement
  9. S-8 Other Securities Offered to Employees in Benefit Plans
  10. 8-K Event Results of operations
  11. 10-K Report Annual Report
  12. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 8-K Event Regulation FD disclosure
  20. 4 Insider Changes in Ownership

Page 5 of 42 · 823 filings